20485 ⎘
Medicinal preparations containing organic active ingredients; Salicylic acid; Derivatives thereof Amides, e.g. salicylamide
Combination Therapy for Brain Cancer
#2COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS
#3CATALYTIC INHIBITOR OF PROTEIN PHOSPHATASE 5 ACTIVATES THE EXTRINSIC APOPTOTIC PATHWAY BY DISRUPTING COMPLEX II
#4ANTI IL-6 DOMAIN ANTIBODIES WITH FATTY ACID SUBSTITUENTS
#5METHOD AND EQUIPMENT FOR FRACTIONATION OF GRANULES FOR USE IN PHARMACEUTICAL COMPOSITIONS
#6Pharmaceutical Composition Containing GLP-1 Compound
#7PHARMACEUTICAL COMPOSITION COMPRISING NICLOSAMIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PREPARATION METHOD THEREFOR
#8ANTI IL-6 DOMAIN ANTIBODIES
#9COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY CONDITIONS
#10METHOD FOR AMELIORATING PROGRESSION OF RENAL FIBROSIS AND TREATING RENAL FIBROSIS BY 5-(2',4'-DIFLUOROPHENYL)-SALICYLANILIDE DERIVATIVES
#11NICLOSAMIDE NASAL AND THROAT SPRAY
#12ACTIVE AGENT COMBINATION FOR TREATMENT OF CANCER
#13Methods for the Prevention and Treatment of Hearing Loss
#14Methods for the Prevention and Treatment of Hearing Loss
#15TREATMENT
#16Method of Treating COVID-19
#17PHARMACEUTICAL COMPOSITIONS WITH ANTIFLAVIVIRAL ACTIVITY
#18COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS
#19PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR RELIEVING PROGRESSION OF CHRONIC KIDNEY DISEASE OR PREVENTING THEREOF
#20FORMULATIONS USING LITHIUM TO TREAT GOUT ARTHROPATHY
#21METHOD AND EQUIPMENT FOR FRACTIONATION OF GRANULES FOR USE IN PHARMACEUTICAL COMPOSITIONS
#22HALOGENATED SALICYLANILIDES FOR THE TREATMENT OF DERMATITIS
#23TFAP2 INHIBITION FOR TREATING CARDIAC DISEASE INVOLVING FIBRO-FATTY REPLACEMENT
#24Method for treating dupuytren's disease
#25Inhibition of thymine DNA glycosylase in the treatment of cancer
#26HALOGENATED SALICYLANILIDES FOR TREATING THE SYMPTOMS OF DERMATITIS
#27SOS1 ALLOSTERIC SITE TARGETING
#28Pharmaceutical compositions of niclosamide
#29Materials and methods for the development of an antigen-specific immune non-responsiveness state
#30Halogenated salicylanilides for treating infections
#31FATTY ACID ACETYLATED SALICYLATES AND THEIR USES
#32TREATMENT OF INFECTIONS CAUSED BY NEISSERIA GONOCOCCUS USING A HALOGENATED SALICYLANILIDE
#33Compositions and methods for the treatment of fungal infections
#34Antibacterial use of halogenated salicylanilides
#35Antibacterial use of halogenated salicylanilides
#36Antibacterial use of halogenated salicylanilides
#37PRESERVATION OF THE NEUROMUSCULAR JUNCTION AFTER TRAUMATIC NERVE INJURY
#38Compositions and methods for inhibiting biofilm-forming bacteria
#39Method of treating metabolic disorders and depression with dopamine receptor agonists
#40Methods of preventing platelet activation
#41ORAL B12 THERAPY
#42Compounds and methods for treatment and prevention of Flavivirus infection
#43Halogenated salicylanilides for treating infections
#44FATTY ACID ACETYLATED SALICYLATES AND THEIR USES
#45Treatment of metastatic prostate cancer
#46MATERIALS AND METHODS FOR THE DEVELOPMENT OF AN ANTIGEN-SPECIFIC IMMUNE NON-RESPONSIVENESS STATE
#47Method of treating metabolic disorders and depression with dopamine receptor agonists
#48Pharmaceutical compositions with antiflaviviral activity
#49Compositions and methods for the treatment of fungal infections
#50Non-aqueous topical compositions comprising a halogenated salicylanilide
#51Antibacterial use of halogenated salicylanilides
#52APPLICATION OF 4-HYDROXY SALICYLANILIDE IN PREPARATION OF ANTI-MYELOMA OR ANTI-LYMPHOMA DRUGS
#53FATTY ACID ACETYLATED SALICYLATES AND THEIR USES
#54Halogenated salicylanilides for treating clostridium infections
#55PHARMACEUTICAL FORMULATION COMPRISING A SUBSTITUTED PHENYL - (1,3-DIHYDRO-ISOINDOL-2-YL) - METHANONE
#56Method of treating metabolic disorders and depression with dopamine receptor agonists
#57Method of treating or prevention of atherothrombotic events in patients with history of myocardial infarction
#58Antibacterial use of halogenated salicylanilides
#59Antibacterial Use of Halogenated Salicylanilides
#60FATTY ACID ACETYLATED SALICYLATES AND THEIR USES
#61MATERIALS AND METHODS FOR THE DEVELOPMENT OF AN ANTIGEN-SPECIFIC IMMUNE NON-RESPONSIVENESS STATE
#62DRUG DELIVERY COMPOSITIONS AND METHODS OF USE
#63MODULATION OF EPIGENETIC STRESS RESPONSE
#64Identification of small molecules that facilitate therapeutic exon skipping
#65Inhibition of thymine DNA glycosylase in the treatment of cancer
#66Compositions and methods for the treatment of fungal infections
#67ORAL B12 THERAPY
#68Heparin-based compositions and methods for the inhibition of metastasis
#69Niclosamide and its derivatives for use in the treatment of solid tumors
#70Heparin-based compositions and methods for the inhibition of metastasis
#71Granules for pharmaceutical preparations, methods and apparatus for their production
#72Aromatic carboxylic acids in combination with aromatic hydroxyamides for inactivating non-enveloped viruses
#73Pharmaceutical composition of salicylanilide-derived small molecules and preparation and application thereof
#74TREATMENT OF TYPE II DIABETES AND DIABETES-ASSOCIATED DISEASES WITH SAFE CHEMICAL MITOCHONDRIAL UNCOUPLERS
#75Di-aspirin derivatives
#76Granules for pharmaceutical preparations, methods and apparatus for their production
#77Heparin-based compositions and methods for the inhibition of metastasis
#78Fatty acid acetylated salicylates and their uses
#79Fatty acid acetylated salicylates and their uses
#80Fatty acid acetylated salicylates and their uses
#81Fatty acid acetylated salicylates and their uses
#82Use of Calcitonin for the Treatment of RA
#83MATERIALS AND METHODS FOR THE DEVELOPMENT OF AN ANTIGEN-SPECIFIC IMMUNE NON-RESPONSIVENESS STATE
#84PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF SALICYLANILIDES FOR TREATMENT OF HEPATITIS VIRUSES
#85N-acyl anthranilic acid derivative or salt thereof
#86Oral B12 Therapy
#87PPAR-Gamma Agonists for the Induction of Cationic Antimicrobial Peptide Expression as Immunoprotective Stimulants
#88Processed starch powder with excellent disintegration properties and manufacturing method thereof
#89Treating alzheimer's disease and osteoporosis and reducing aging
#90Antibiotic compound
#91Fatty acid acetylated salicylates and their uses
#92Balsalazide formulations and manufacture and use thereof
#93Topical cromolyn formulations
#94METHOD OF TREATING METABOLIC DISORDERS AND DEPRESSION WITH DOPAMINE RECEPTOR AGONISTS
#95Use of calcitonin for the treatment of RA
#96ANTIALLERGIC AGENTS
#97Composition and method of treating peripheral neuropathy
#98Antiallergic agents
#99Antiallergic agents
#100Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
#101Parasiticidal composition
#102Antiallergic
#103Composition comprising an aqueous extract of red vine leaves and an antithrombotic agent
#104Methods of preventing platelet activation
#105Methods of preventing platelet activation